CN1311072C - Preparation method of dried active amnion - Google Patents
Preparation method of dried active amnion Download PDFInfo
- Publication number
- CN1311072C CN1311072C CNB2005100468563A CN200510046856A CN1311072C CN 1311072 C CN1311072 C CN 1311072C CN B2005100468563 A CNB2005100468563 A CN B2005100468563A CN 200510046856 A CN200510046856 A CN 200510046856A CN 1311072 C CN1311072 C CN 1311072C
- Authority
- CN
- China
- Prior art keywords
- amnion
- amnions
- paper
- epithelial
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000001691 amnion Anatomy 0.000 title claims abstract description 72
- 238000002360 preparation method Methods 0.000 title claims description 13
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 19
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 19
- 210000004027 cell Anatomy 0.000 claims abstract description 17
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims abstract description 10
- 210000001136 chorion Anatomy 0.000 claims abstract description 10
- 210000002919 epithelial cell Anatomy 0.000 claims abstract description 9
- 210000005059 placental tissue Anatomy 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 229920000742 Cotton Polymers 0.000 claims abstract description 3
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 claims description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 15
- 238000011010 flushing procedure Methods 0.000 claims description 15
- 238000004108 freeze drying Methods 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000009461 vacuum packaging Methods 0.000 claims 1
- 239000002504 physiological saline solution Substances 0.000 abstract description 8
- 238000002054 transplantation Methods 0.000 abstract description 8
- 238000000034 method Methods 0.000 abstract description 6
- 102000004142 Trypsin Human genes 0.000 abstract description 4
- 108090000631 Trypsin Proteins 0.000 abstract description 4
- 210000000981 epithelium Anatomy 0.000 abstract description 4
- 239000012588 trypsin Substances 0.000 abstract description 4
- 238000002513 implantation Methods 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 229960001484 edetic acid Drugs 0.000 abstract 2
- 241000500881 Lepisma Species 0.000 abstract 1
- 230000002070 germicidal effect Effects 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 210000002826 placenta Anatomy 0.000 description 21
- 241000711549 Hepacivirus C Species 0.000 description 14
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 7
- 241000701022 Cytomegalovirus Species 0.000 description 7
- 241000700721 Hepatitis B virus Species 0.000 description 7
- 206010061598 Immunodeficiency Diseases 0.000 description 7
- 208000029462 Immunodeficiency disease Diseases 0.000 description 7
- 229930182555 Penicillin Natural products 0.000 description 7
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 7
- 241000589884 Treponema pallidum Species 0.000 description 7
- 241000700605 Viruses Species 0.000 description 7
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 7
- 229960003942 amphotericin b Drugs 0.000 description 7
- 230000003115 biocidal effect Effects 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 230000007813 immunodeficiency Effects 0.000 description 7
- 229940049954 penicillin Drugs 0.000 description 7
- 238000004321 preservation Methods 0.000 description 7
- 230000000405 serological effect Effects 0.000 description 7
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 210000000721 basilar membrane Anatomy 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 210000002219 extraembryonic membrane Anatomy 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241001330002 Bambuseae Species 0.000 description 1
- 208000009043 Chemical Burns Diseases 0.000 description 1
- 208000018380 Chemical injury Diseases 0.000 description 1
- 102000012432 Collagen Type V Human genes 0.000 description 1
- 108010022514 Collagen Type V Proteins 0.000 description 1
- 102000002734 Collagen Type VI Human genes 0.000 description 1
- 108010043741 Collagen Type VI Proteins 0.000 description 1
- 206010011033 Corneal oedema Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 201000004778 corneal edema Diseases 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000008508 epithelial proliferation Effects 0.000 description 1
- 229940059659 erythromycin ophthalmic ointment Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000001232 limbus corneae Anatomy 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 208000021165 scleral disease Diseases 0.000 description 1
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002993 trophoblast Anatomy 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a method for preparing dried active amnions. In the method, healthy placenta tissues are adopted for carrying out germicidal processing for separating amnions from chorions; spongy layers are scraped off; afterwards, epithelial surfaces are upwards laid and fixed on nitrocellulose paper; paper sheets with amnions are sheared into proper sizes and are incubated in the mixed liquid of 0.05% to 0.5% of trypsin and 0.01% to 0.1% of ethylene diamine tetraacetic acid or 0.05% to 0.5% of trypsin or 0.01% to 0.1% of ethylene diamine tetraacetic acid liquid at 37 DEG C for 1/2 hour to 4 hours; a cell slicker or a cotton rod is used for removing epithelial cells; the amnions are washed by physiological saline repeatedly and are put in a freeze dryer after the fact that epithelial surfaces have no cell under microscopes is verified; the amnions and the nitrocellulose paper are frozen and dried together under the vacuum condition and are packed in vacuum at room temperature; finally, the amnions are irradiated by gamma rays. The method has the advantages that the cells in the amnions are removed, effective substrate active components in the cells are simultaneously reserved, the dried active amnions can be widely applied to amnion covering operations, amnion transplantation operations, amnion filling implantation operations, etc. in ophthalmology, and the dried active amnions can also be used as new tissue engineering materials for the cultivation and the transplantation of epitheliums and endothelia.
Description
Affiliated technical field
The present invention relates to medical amniotic membrane preparations, especially a kind of preparation method who takes off the cell dried active amnion with long preservation period.
Background technology
Amnion is to develop from cytotrophoblast, is the internal layer of human two-layer fetal membrane, is basilar membrane the thickest in the human body.The no blood vessel of amnion self and neural, lymphatic vessel, its antigenicity lower (mainly coming from cellular constituent wherein).The application of amnion starts from 1910 the earliest, and Divis is used for transplanting to fetal membrane (amnion+chorion) first and achieves success.Then, amnion is widely used in various operations as burned skin graft, artificial vaginal mucosa sheath etc., carries out amnion transplantation up to nineteen ninety-five Kim and Tseng at the anterior corneal surface of chemical burn mould shape, and amnion transplantation causes oculistic attention gradually.1997, Ma etc. studied the feasibility of amnion transplantation from the molecular biology angle, and the mechanism of action of amnion is mainly: 1. basilar membrane effect for stem cell provides " fertile soil ", provides shiny surface to be beneficial to the cell growth; 2. wherein various albumen compositions can promote epithelium differentiation, hyperplasia; 3. strengthen the albumen adhesivity, promote the epithelial proliferation reparation; 4. the proteolytic enzyme arrestin enzyme that contains of amnion and bring into play it and press down scorching effect; 5. amnion contains the composition that suppresses cytokine-expressing and natural death of cerebral cells; 6. can avoid the keratocyte that inflammatory cytokine brings out and the hyperplasia of collegen filament, thereby suppress local inflammation, promote the surface healing and do not stay scar.
In recent years, along with the continuous development of people to amnion research, amnion transplantation by broader applications in the treatment ophthalmic diseases.Amnion covering operation, Transplantation of amniotic membrane, amnion filling, implantation etc. have improved the treatment success ratio of illness in eye such as comprising eye surface diseases, glaucoma, sclera disease.
The amnion that uses clinically mostly is fresh amnion or profound hypothermia preservation amnion at present, is difficult to accomplish ready access upon use, the convenient preservation.Though but patent publication No. is the freeze-drying amnions of the bioamnion goods of CN1522568A for the normal temperature preservation, it does not slough the cell of amnion, brings difficulty to clinical application, and can not carry out epithelium, endothelium cultivation transplanting as the organizational engineering material.
Summary of the invention
The objective of the invention is to: at the problems referred to above, but but the broader applications that a kind of prolonged preservation, ready access upon use be provided in the preparation method of clinical dried active amnion goods.
Concrete technical scheme is as follows: the preparation method of dried active amnion is: select for use health to cut open the placenta tissue that the puerpera is produced in the palace, antenatal Serological testing is got rid of hepatitis B virus (HBV), hepatitis C virus (HCV) cytomegalovirus, treponema pallidum and immunodeficiency virus (HIV) according to relevant national standard and is infected.Obtain promptly to operate down behind the placenta from c-section or aseptic the delivering a child of natural labor, make following sterilising treatment: with the bloodstain on the clean placenta of normal saline flushing surface aseptic; Soak 5～10 minutes (concentration of microbiotic mixed solution is for containing 50ug/ml penicillin, 50ug/ml Streptomycin sulphate, 100ug/ml Xin Meisu and 2.5ug/ml amphotericin B) of placenta with containing antibiotic stroke-physiological saline solution.
Amnion is separated from chorion, scraped off spongy layer with blade or slide glass side as far as possible, epithelial surface tiles up and is fixed in (Bio-Tissue company provides) on the cellulose nitrate paper then, will have the scraps of paper of amnion to be cut into suitable size then.Again in the mixed solution of 0.05～0.5% trypsinase and 0.01～0.1%EDTA or 0.05～0.5% trypsinase or 0.01～0.1%EDTA liquid 37 ℃ hatched 1/2-4 hour, slough epithelial cell with cell sleaker or cotton rod, normal saline flushing repeatedly, microscopically confirm that epithelial surface is acellular.Insert Freeze Drying Equipment, together with the freeze-drying of cellulose nitrate paper, at room temperature row is vacuum-packed under the vacuum condition.Last gammairradiation.Every batch of product sampling carrying out bacterium cultivation.
The amnion such as the bamboo paper sample of above method preparation, translucent, about 20 microns of thickness, tension stress and line shear force performance are good after the rehydration, and the transparency increases when dry.
The preparation method of dried active amnion of the present invention, sloughed entamniotic cell, greatly reduced the antigenicity of amnion, kept its effective matrix activeconstituents simultaneously, can wider model be used in the operations such as ophthalmology amnion covering operation, Transplantation of amniotic membrane, amnion filling, implantation, and can be used as novel organizational engineering material and transplant in order to the cultivation of epithelium, endothelium.After the lyophilize, the preservation condition that makes amnion is normal temperature (dry shady and cool place), and validity period can reach 1 year, has accomplished ready access upon use, the convenient preservation.Aseptic manipulation and gammairradiation sterilization have overcome fresh or the contaminated possibility of cryopreservation amnion.Amniotic membrane preparations of the present invention and cellulose nitrate paper together freeze-drying are preserved, and clip is convenient during use.
Embodiment
The present invention is described in detail below in conjunction with embodiment, but embodiments of the present invention are not limited thereto.
Embodiment 1:
Select for use health to cut open the placenta tissue that the puerpera is produced in the palace, antenatal Serological testing is got rid of hepatitis B virus (HBV), hepatitis C virus (HCV) cytomegalovirus, treponema pallidum and immunodeficiency virus (HIV) according to relevant national standard and is infected.Obtain promptly to operate down behind the placenta from c-section or aseptic the delivering a child of natural labor, make following sterilising treatment: with the bloodstain on the clean placenta of normal saline flushing surface aseptic; Soak 5～10 minutes (concentration of microbiotic mixed solution is for containing 50ug/ml penicillin, 50ug/ml Streptomycin sulphate, 100ug/ml Xin Meisu and 2.5ug/ml amphotericin B) of placenta with containing antibiotic stroke-physiological saline solution.
Amnion is separated from chorion, scraped off spongy layer with the slide glass side as far as possible, epithelial surface tiles up and is fixed in (Bio-Tissue company provides) on the cellulose nitrate paper then, will have the scraps of paper of amnion to be cut into 6cm * 2.5cm size then.Again in 0.02%EDTA liquid 37 ℃ hatched 3 hours, slough epithelial cell with the cell sleaker, normal saline flushing repeatedly, microscopically confirm that epithelial surface is acellular.Together with the freeze-drying of cellulose nitrate paper, at room temperature row is vacuum-packed under the vacuum condition.Last gammairradiation.
Embodiment 2:
Select for use health to cut open the placenta tissue that the puerpera is produced in the palace, antenatal Serological testing is got rid of hepatitis B virus (HBV), hepatitis C virus (HCV) cytomegalovirus, treponema pallidum and immunodeficiency virus (HIV) according to relevant national standard and is infected.Obtain promptly to operate down behind the placenta from c-section or aseptic the delivering a child of natural labor, make following sterilising treatment: with the bloodstain on the clean placenta of normal saline flushing surface aseptic; Soak 5～10 minutes (concentration of microbiotic mixed solution is for containing 50ug/ml penicillin, 50ug/ml Streptomycin sulphate, 100ug/ml Xin Meisu and 2.5ug/ml amphotericin B) of placenta with containing antibiotic stroke-physiological saline solution.
Amnion is separated from chorion, scraped off spongy layer with the slide glass side as far as possible, epithelial surface tiles up and is fixed in (Bio-Tissue company provides) on the cellulose nitrate paper then, will have the scraps of paper of amnion to be cut into 6cm * 2.5cm size then.Again in 0.25% trypsin solution 37 ℃ hatched 2 hours, help to slough epithelial cell with the cell sleaker, normal saline flushing repeatedly, microscopically confirms that epithelial surface is acellular.Together with the freeze-drying of cellulose nitrate paper, at room temperature row is vacuum-packed under the vacuum condition.Last gammairradiation.
Embodiment 3:
Select for use health to cut open the placenta tissue that the puerpera is produced in the palace, antenatal Serological testing is got rid of hepatitis B virus (HBV), hepatitis C virus (HCV) cytomegalovirus, treponema pallidum and immunodeficiency virus (HIV) according to relevant national standard and is infected.Obtain promptly to operate down behind the placenta from c-section or aseptic the delivering a child of natural labor, make following sterilising treatment: with the bloodstain on the clean placenta of normal saline flushing surface aseptic; Soak 5～10 minutes (concentration of microbiotic mixed solution is for containing 50ug/ml penicillin, 50ug/ml Streptomycin sulphate, 100ug/ml Xin Meisu and 2.5ug/ml amphotericin B) of placenta with containing antibiotic stroke-physiological saline solution.
Amnion is separated from chorion, scraped off spongy layer with the slide glass side as far as possible, epithelial surface tiles up and is fixed in (Bio-Tissue company provides) on the cellulose nitrate paper then, will have the scraps of paper of amnion to be cut into 4cm * 2.5cm size then.Again in 0.05%EDTA liquid 37 ℃ hatched 3 hours, help to slough epithelial cell with the cell sleaker, normal saline flushing repeatedly, microscopically confirms that epithelial surface is acellular.Together with the freeze-drying of cellulose nitrate paper, at room temperature row is vacuum-packed under the vacuum condition.Last gammairradiation.
Embodiment 4:
Select for use health to cut open the placenta tissue that the puerpera is produced in the palace, antenatal Serological testing is got rid of hepatitis B virus (HBV), hepatitis C virus (HCV) cytomegalovirus, treponema pallidum and immunodeficiency virus (HIV) according to relevant national standard and is infected.Obtain promptly to operate down behind the placenta from c-section or aseptic the delivering a child of natural labor, make following sterilising treatment: with the bloodstain on the clean placenta of normal saline flushing surface aseptic; Soak 5～10 minutes (concentration of microbiotic mixed solution is for containing 50ug/ml penicillin, 50ug/ml Streptomycin sulphate, 100ug/ml Xin Meisu and 2.5ug/ml amphotericin B) of placenta with containing antibiotic stroke-physiological saline solution.
Amnion is separated from chorion, scraped off spongy layer with the slide glass side as far as possible, epithelial surface tiles up and is fixed in (Bio-Tissue company provides) on the cellulose nitrate paper then, will have the scraps of paper of amnion to be cut into 6cm * 2.5cm size then.Again in 0.25% trypsinase and 0.02%EDTA mixed solution 37 ℃ hatched 1 hour, help to slough epithelial cell with the cell sleaker, normal saline flushing repeatedly, microscopically confirms that epithelial surface is acellular.Together with the freeze-drying of cellulose nitrate paper, at room temperature row is vacuum-packed under the vacuum condition.Last gammairradiation.
Embodiment 5:
Select for use health to cut open the placenta tissue that the puerpera is produced in the palace, antenatal Serological testing is got rid of hepatitis B virus (HBV), hepatitis C virus (HCV) cytomegalovirus, treponema pallidum and immunodeficiency virus (HIV) according to relevant national standard and is infected.Obtain promptly to operate down behind the placenta from c-section or aseptic the delivering a child of natural labor, make following sterilising treatment: with the bloodstain on the clean placenta of normal saline flushing surface aseptic; Soak 5～10 minutes (concentration of microbiotic mixed solution is for containing 50ug/ml penicillin, 50ug/ml Streptomycin sulphate, 100ug/ml Xin Meisu and 2.5ug/ml amphotericin B) of placenta with containing antibiotic stroke-physiological saline solution.
Amnion is separated from chorion, scraped off spongy layer with the slide glass side as far as possible, epithelial surface tiles up and is fixed in (Bio-Tissue company provides) on the cellulose nitrate paper then, will have the scraps of paper of amnion to be cut into 6cm * 2.5cm size then.Again in 0.2% trypsinase and 0.05%EDTA mixed solution 37 ℃ hatched 1 hour, help to slough epithelial cell with the cell sleaker, normal saline flushing repeatedly, microscopically confirms that epithelial surface is acellular.Together with the freeze-drying of cellulose nitrate paper, at room temperature row is vacuum-packed under the vacuum condition.Last gammairradiation.
Embodiment 6:
Select for use health to cut open the placenta tissue that the puerpera is produced in the palace, antenatal Serological testing is got rid of hepatitis B virus (HBV), hepatitis C virus (HCV) cytomegalovirus, treponema pallidum and immunodeficiency virus (HIV) according to relevant national standard and is infected.Obtain promptly to operate down behind the placenta from c-section or aseptic the delivering a child of natural labor, make following sterilising treatment: with the bloodstain on the clean placenta of normal saline flushing surface aseptic; Soak 5～10 minutes (concentration of microbiotic mixed solution is for containing 50ug/ml penicillin, 50ug/ml Streptomycin sulphate, 100ug/ml Xin Meisu and 2.5ug/ml amphotericin B) of placenta with containing antibiotic stroke-physiological saline solution.
Amnion is separated from chorion, scraped off spongy layer with the slide glass side as far as possible, epithelial surface tiles up and is fixed in (Bio-Tissue company provides) on the cellulose nitrate paper then, will have the scraps of paper of amnion to be cut into 6cm * 2.5cm size then.Again in 0.2% trypsin solution 37 ℃ hatched 2.5 hours, help to slough epithelial cell with the cell sleaker, normal saline flushing repeatedly, microscopically confirms that epithelial surface is acellular.Together with the freeze-drying of cellulose nitrate paper, at room temperature row is vacuum-packed under the vacuum condition.Last gammairradiation.
The amnion of above method preparation carries out immunohistochemical experiment and shows that holostrome exists I type, III type, IV type and collagen type v and fiber adhesion element in the lyophilize amnion, and VII Collagen Type VI and Kallinin are present in the basilar membrane side.Close with position, the quantity of activeconstituents in the fresh amnion.
Choose 5 12～14 age in week body weight at New Zealand's large ear rabbit (male and female are not limit) of 1.5～2.5kg, the quiet notes general anesthesia of 15g/L Veronal sodium, 3.0mm place otch in corneal limbus, make the flaggy pocket, the amniotic membrane preparations of implanting top method preparation is in rabbit corneal matrix, do not do stitching, postoperative erythromycin ophthalmic ointment routine is coated with the art eye.In the time of one month, slit lamp observation sees that to implant the amnion consistency good, transparent, does not see that local cells infiltration, corneal edema and new vessel grow into; The visible keratocyte of pathological examination is grown in implanting amnion.Confirmed this dried active amnion excellent biological compatibility.
Claims (1)
1, a kind of preparation method of dried active amnion is characterized in that selecting for use healthy placenta tissue, carries out sterilising treatment, amnion is separated from chorion, scrape off spongy layer, epithelial surface tiles up and is fixed on the cellulose nitrate paper then, will have the scraps of paper of amnion to be cut into suitable size then; Again in the mixed solution of 0.05～0.5% trypsinase and 0.01～0.1%EDTA or 0.05～0.5% trypsinase or 0.01～0.1%EDTA liquid 37 ℃ hatched 1/2-4 hour, slough epithelial cell with cell sleaker or cotton rod, normal saline flushing repeatedly, microscopically confirm that epithelial surface is acellular; Insert Freeze Drying Equipment, together with the freeze-drying of cellulose nitrate paper, at room temperature carry out vacuum packaging under the vacuum condition; Last gammairradiation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100468563A CN1311072C (en) | 2005-07-12 | 2005-07-12 | Preparation method of dried active amnion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100468563A CN1311072C (en) | 2005-07-12 | 2005-07-12 | Preparation method of dried active amnion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1757717A CN1757717A (en) | 2006-04-12 |
| CN1311072C true CN1311072C (en) | 2007-04-18 |
Family
ID=36703286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100468563A Active CN1311072C (en) | 2005-07-12 | 2005-07-12 | Preparation method of dried active amnion |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1311072C (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8372437B2 (en) | 2006-08-17 | 2013-02-12 | Mimedx Group, Inc. | Placental tissue grafts |
| EP2197270B8 (en) | 2007-09-07 | 2020-03-04 | Surgical Biologics, LLC | Placental tissue grafts and improved methods of preparing and using the same |
| CN101889569B (en) * | 2010-07-23 | 2013-05-22 | 马吉献 | Method for drying and storing biological amnion |
| KR20240042159A (en) | 2011-02-14 | 2024-04-01 | 미메딕스 그룹 인크. | Micronized placental tissue compositions and methods for making and using the same |
| CN102225217A (en) * | 2011-06-23 | 2011-10-26 | 天津世纪康泰生物医学工程有限公司 | Preparation method of acellular dried active amnion |
| CN107335095A (en) * | 2017-06-05 | 2017-11-10 | 江西瑞诺健医学科技有限公司 | A kind of preparation method of medical multilayer placenta tissue implant |
| CN107714609A (en) * | 2017-11-08 | 2018-02-23 | 郑楠 | A kind of amnion basement membrane, amnion facial mask based on amnion basement membrane and preparation method thereof |
| CN108126246A (en) * | 2017-12-29 | 2018-06-08 | 山西医科大学 | Artificial skin construction method based on compound stem cell |
| CN110946879B (en) * | 2018-09-26 | 2021-05-11 | 成都清科生物科技有限公司 | Acellular biological amniotic membrane containing loose layer and preparation method thereof |
| US20210244845A1 (en) * | 2020-02-10 | 2021-08-12 | Leslie MARCELIN | Method Of Processing Amnion To Form A Suture |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1088118A (en) * | 1992-12-15 | 1994-06-22 | 吕平 | Medical protective tectorial membrane for surfaces of wound |
| CN1522568A (en) * | 2003-09-03 | 2004-08-25 | 江西省科学院住友生物工程技术有限公 | Amnia preservation and handling method |
-
2005
- 2005-07-12 CN CNB2005100468563A patent/CN1311072C/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1088118A (en) * | 1992-12-15 | 1994-06-22 | 吕平 | Medical protective tectorial membrane for surfaces of wound |
| CN1522568A (en) * | 2003-09-03 | 2004-08-25 | 江西省科学院住友生物工程技术有限公 | Amnia preservation and handling method |
Non-Patent Citations (4)
| Title |
|---|
| 人羊膜的制备及其在眼科临床中的应用 易敬林 等，江西医学院学报，第43卷第6期 2003 * |
| 保存人羊膜移植治疗难治性眼表疾病的临床效果 易敬林 等，中国实用眼科杂志，第22卷第2期 2004 * |
| 保存人羊膜移植治疗难治性眼表疾病的临床效果 易敬林 等，中国实用眼科杂志，第22卷第2期 2004;人羊膜的制备及其在眼科临床中的应用 易敬林 等，江西医学院学报，第43卷第6期 2003;羊膜移植在眼科的临床应用 胡辅华，中国交通医学杂志，第18卷第1期 2004 * |
| 羊膜移植在眼科的临床应用 胡辅华，中国交通医学杂志，第18卷第1期 2004 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1757717A (en) | 2006-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5993387B2 (en) | Collagen biofiber and its preparation method and use | |
| US6326019B1 (en) | Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries | |
| CN100503814C (en) | Methods of preparing a transplantable product for treatment of skin defects | |
| ES2767252T3 (en) | Umbilical cord amniotic membrane products | |
| WO2005087286A1 (en) | Biological tissue sheet, method of forming the same and transplantation method by using the sheet | |
| CN1311072C (en) | Preparation method of dried active amnion | |
| CN108939161B (en) | A kind of humanization activity goes the preparation method of cell corneal stroma stent | |
| CN1799558A (en) | A kind of gel-linked amniotic membrane and preparation method thereof | |
| CN100386061C (en) | A frozen heterogeneous corneal stroma with low antigen content and its preparation method | |
| CN1253559C (en) | Production method of transplanting material | |
| Miljudin et al. | Silica gel dissication of amniotic membrane with related epithelium cells for ocular surface reconstruction | |
| Sharma et al. | Limbal stem cell transplants and amniotic membrane grafts in ocular surface disease: current perspectives. | |
| CN1327911C (en) | Epiderm substitute in tissue engineering and its prepn process | |
| CN118924956A (en) | A hyaluronic acid oligosaccharide-chitosan biomimetic thermosensitive gel encapsulating extracellular vesicles derived from hemangioma stem cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SHENYANG SHANGSHAN MEDICAL INSTRUMENTS CO., LTD. Free format text: FORMER OWNER: HE WEI Effective date: 20091127 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20091127 Address after: No. 36-36, forest road, Dongling District, Liaoning, Shenyang Patentee after: Shenyang sunmed medical instrument Ltd. Address before: No. 128 North Main Street, Huanggu District, Shenyang, Liaoning, the Yellow River Patentee before: He Wei |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200219 Address after: 110163 No. 66, Surabaya street, Dongling District, Liaoning, Shenyang Patentee after: SHENYANG HESHI EYE INDUSTRY GROUP CO.,LTD. Address before: No.36-36, Linlin Road, Dongling District, Shenyang City, Liaoning Province Patentee before: Shenyang sunmed medical instrument Ltd. |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20230928 Address after: 110163 Surabaya street, Hunnan District, Shenyang, Liaoning 66 Patentee after: SHENYANG BAIAO MEDICAL DEVICES CO.,LTD. Address before: No. 66, Sishui street, Dongling District, Shenyang City, Liaoning Province Patentee before: SHENYANG HESHI EYE INDUSTRY GROUP CO.,LTD. |
|
| TR01 | Transfer of patent right |